VLA 0.00% $1.75 viralytics limited

AGM, page-4

  1. 67 Posts.
    A possible question for AGM:
    Some patient tumours have displayed resistance to check point inhibitor therapy over time in other studies, how much of a risk is this for our combination therapies?
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.